ABSTRACT
UNLABELLED: We have developed a new biopotential fiber sensor (BFS) technology as an alternative to traditional wet-gel Ag/AgCl electrodes in long-term monitoring applications. Biopotential fiber sensor technology uses proprietary method of bonding copper sulfide to the surface of acrylic fibers, thus creating an electrically conductive medium (10(-1) ohms/cm). Surface modified bundles of acrylic fibers form stable biopotential sensors when doped with proprietary ink comprising organic acids and nano particles of Ag and AgCl. Biopotential fiber sensors are characterized by a small footprint 0.1 mm2 and low mass of 0.005 g. Biopotential fiber sensor systems are disposable 1-piece assemblies combining the functions of the electrodes, lead wires and a patient cable. METHODS: The electric performance characteristics of BFS were obtained according to American National Standards Institute/Association for the Advancement of Medical Instrumentation EC-12:2000 standard and compared with Ag/AgCl wet-gel electrodes. The noise characteristics were determined from 250 hours of 3-lead electrocardiographic (ECG) data recorded with BFS over a period of 10 days from healthy volunteers. RESULTS: The BFS direct current offset voltage was 0.11 mV and alternate current impedance at 10 Hz was 22 ohms. The sensors average longevity on the body surface with no detachments was at least 7 days. BFS demonstrated high immunity to motion and electric field-induced artifacts. CONCLUSIONS: Biopotential fiber sensors are well suited for routine long-term ECG monitoring applications because of increased patient comfort through integration of the electrode, lead wire, and a patient cable, which function into one disposable BFS fiber assembly. Biopotential fiber sensor have electrical characteristics comparable to Ag/AgCl wet electrodes. We observed an improved ECG signal quality, reduced frequent electrode detachments, reduced wire clutter and entanglement, and improved sensor adherence to the skin over longer periods of time.
Subject(s)
Action Potentials/physiology , Electrocardiography/instrumentation , Electrodes , Heart Conduction System/physiology , Transducers , Copper/chemistry , Electric Conductivity , Equipment Design , Equipment Failure Analysis , HumansABSTRACT
BACKGROUND: Thrombolytic therapy can be life-saving in patients with acute myocardial infarction. However, if given too late or insufficiently selectively, it may provide little benefit but still cause serious complications and incur substantial costs. OBJECTIVE: To develop a thrombolytic predictive instrument for real-time use in emergency medical service settings that could 1) identify patients likely to benefit from thrombolysis and 2) facilitate the earliest possible use of this therapy. DESIGN: Creation and validation of logistic regression-based predictive instruments based on secondary analysis of clinical data. PATIENTS: 4911 patients who had acute myocardial infarction and ST-segment elevation on electrocardiogram; 3483 received thrombolytic therapy. MEASUREMENTS: Data were obtained from 13 major clinical trials and registries and directly from medical records, including electrocardiograms obtained at presentation. Input variables include presenting clinical and electrocardiography features; predictive models generate probabilities for acute (30-day) mortality if and if not treated with thrombolysis, 1-year mortality rates if and if not treated with thrombolysis, cardiac arrest if and if not treated with thrombolysis, thrombolysis-related intracranial hemorrhage, and thrombolysis-related major bleeding episode requiring transfusion. Together, these models constitute the thrombolytic predictive instrument. RESULTS: The predictive models generated the following mean predictions for patients in the Thrombolytic Predictive instrument Database: 30-day mortality rate, 7.1%; 1-year mortality rate, 10.9%; rate of cardiac arrest, 3.7%; rate of thrombolysis-related intracranial hemorrhage. 0.6%; and rate of other thrombolysis-related major bleeding episodes, 5.0%. They discriminated with between persons having and those not having the predicted outcome; areas under the receiver-operating characteristic (ROC) curve were between 0.77 and 0.84 for the five outcomes. Calibration between each instrument's predicted and observed served rates was excellent. Validation of the predictive instruments of 30-day and 1-year mortality, done on a separate test dataset, yielded areas under the ROC curve of 0.76 for each CONCLUSIONS: After the basic features of a clinical presentation are entered into a computerized electrocardiograph, the predictions of the thrombolytic predictive instrument can be printed on the electrocardiogram report. This decision aid may facilitate earlier and more appropriate use of thrombolytic therapy in patients with acute myocardial infarction.
Subject(s)
Emergency Service, Hospital , Myocardial Infarction/therapy , Therapy, Computer-Assisted , Thrombolytic Therapy , Cerebral Hemorrhage/etiology , Electrocardiography , Heart Arrest/etiology , Hemorrhage/etiology , Humans , Information Systems , Logistic Models , Myocardial Infarction/complications , Myocardial Infarction/mortality , Patient Selection , Time Factors , Treatment OutcomeABSTRACT
Estimating left ventricular wall stress has recognized applications, but formulae for global stress cannot be applied to ischemic ventricles. A mathematic method for estimating regional stress in infarcted ventricles has been described. The hypothesis tested was that exercise-induced ischemia increases end-systolic wall stress. Subcostal four-chamber echocardiograms were recorded at rest and during peak symptom-limited exercise in 19 controls and 41 patients with chest pain undergoing coronary arteriography. Centerline regional wall motion and regional end-systolic wall stress were measured at rest and at peak exercise. The normal controls had increased wall motion with exercise, but wall stress remained low. All 32 of the patients with coronary artery disease (> or = 50% diameter narrowing) had wall motion abnormalities with exercise, but the sensitivity of identifying right coronary artery obstructions was poor. Patients with coronary disease had higher regional stress at peak exercise than did the controls. The sensitivity of identifying lesions in all three coronary arteries (0.95 to 1.0) was better than that for wall motion (p < 0.04). The specificity of wall stress needs to be tested in a larger population. Exercise-induced ischemia causes increased regional end-systolic wall stress that reflects its distribution in patients with coronary artery disease. These changes can be measured non-invasively during exercise echocardiography.
Subject(s)
Coronary Disease/physiopathology , Exercise/physiology , Myocardial Contraction/physiology , Ventricular Function, Left/physiology , Case-Control Studies , Coronary Angiography , Coronary Disease/diagnostic imaging , Echocardiography , Exercise Test , Female , Humans , Image Processing, Computer-Assisted , Male , Middle Aged , Models, Cardiovascular , Models, Theoretical , Reproducibility of Results , Sensitivity and SpecificityABSTRACT
We developed a scoring system to predict the artery responsible for an acute myocardial infarction (AMI) using ST-segment and T-wave changes on the initial electrocardiogram (ECG) using data from 228 patients (development set) with symptoms compatible with AMI and tested in a similar group of 223 patients (test set) from the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-5) Trial. Using stepwise logistic regression we were able to accurately predict the left anterior descending (LAD), right, or left circumflex (LC) coronary artery as the infarct-related artery using 2 variables: (1) the summation of the ST-segment elevation in leads V1 to V4; and (2) the summation of the T-wave negativity in leads I, aVL, and V5. In the development set, these 2 variables demonstrated respective sensitivity and specificity of 98% and 90% for LAD lesions, 82% and 85% for right narrowings, and 82% and 84% for LC narrowings. In the test set, the sensitivity and specificity were 97% and 95% for LAD lesions, 85% and 86% for right lesions, and 73% and 60% for LC coronary artery lesions. Information easily obtained on the ECG can accurately predict the likelihood of the LAD, right, or LC artery as the infarct-related artery. This may be useful in the decision to administer thrombolytic treatment.
Subject(s)
Coronary Vessels/pathology , Electrocardiography/methods , Myocardial Infarction/pathology , Coronary Disease/diagnosis , Coronary Disease/pathology , Electrocardiography/statistics & numerical data , Female , Forecasting , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Myocardial Infarction/drug therapy , ROC Curve , Reproducibility of Results , Sensitivity and Specificity , Thrombolytic Therapy , Treatment OutcomeABSTRACT
RATIONALE AND OBJECTIVES: We compared, in the same human hearts, the ability of magnetic resonance (MR) imaging and electron beam computed tomography (CT) scanning to accurately quantify the free wall and septal components of right ventricular (RV) mass. METHODS: Eleven hearts extracted at autopsy were subjected to MR imaging and electron beam CT scanning in short-axis projections. Regression analyses of mass determinations obtained by manual planimetry MR imaging and electron beam CT scanning and autopsy weights were performed. RESULTS: RV free wall mass by both MR imaging (53.4 +/- 19.1 g) and electron beam CT scanning (53.9 +/- 20.4 g) correlated well with autopsy weight (57.7 +/- 20.2 g). Regression analysis showed a strong correlation for MR imaging (r = .88, slope = .88, standard error the estimate [SEE] = 7.2 g, p < .001) and electron beam CT scanning (r = .95, slope = .95, SEE = 6.6 g, p < .001). RV septal mass by MR imaging (10.8 +/- 3.5 g) and electron beam CT scanning (7.1 +/- 2.4 g) correlated less well with the autopsy weight (12.5 +/- 6.5 g). Regression analysis showed a fair correlation for MR imaging (r = .45, slope = .83, SEE = 2.05 g, p = .001) and a poor correlation for electron beam CT scanning (r = .46, slope = .17, SEE = 2.25 g, p = .57). CONCLUSION: Both MR imaging and electron beam CT scanning accurately predict RV free wall mass but have difficulty predicting the septal component. Because the septal component constitutes only a small proportion of the total RV mass, determinations of RV mass should be based solely on the free wall component.
Subject(s)
Heart/anatomy & histology , Magnetic Resonance Imaging , Tomography, X-Ray Computed , Autopsy , Heart Ventricles/anatomy & histology , Humans , Middle Aged , Observer Variation , Organ Size , Regression AnalysisABSTRACT
RATIONALE AND OBJECTIVES: Validation of right ventricular mass quantitation by electron beam computed tomography in humans has not been performed. The ability of electron beam computed tomography to accurately determine the septal component of the right ventricle also has not been determined. This article addresses both issues. METHODS: Twenty human adult hearts obtained at autopsy were scanned by electron beam computed tomography in a short-axis projection. Planimetry of the right ventricular free wall and septal components of each slice was performed and summed to determine right ventricular mass. These measurements were compared against comparable measurements obtained by autopsy weights of the hearts. RESULTS: Right ventricular free wall weights by electron beam computed tomography (53.9 +/- 18.4 g) correlated well (slope = .92, r = .92, standard error of the estimate = 7.4 g, P < .001) with autopsy weights (55.8 +/- 18.4 g). Right ventricular septal weights by electron beam computed tomography (6.1 +/- 2.3 g) correlated poorly (slope = .04, r = .11, standard error of the estimate = 2.4 g, P = .65) with autopsy weights (13.9 +/- 6.3 g). CONCLUSIONS: Electron beam computed tomography quantitation of right ventricular mass is accurate in humans if only the free wall and not the septal component is utilized.
Subject(s)
Heart Ventricles/diagnostic imaging , Tomography, X-Ray Computed/methods , Aged , Autopsy , Electrons , Heart Ventricles/anatomy & histology , Humans , Linear Models , Middle Aged , Observer Variation , Organ SizeABSTRACT
The thrombolytic predictive instrument (TPI) was developed to identify those patients most likely to benefit from thrombolytic therapy for acute myocardial infarction as well as to facilitate the earliest possible administration of this treatment. The TPI consists of predictive models derived from clinical data obtained from both clinical trials and data registries. These models are subject to potential bias due to combinations of primary data from different sources. The purpose of this investigation was to assess the influence of gender in developing the TPI database. In this database, there were 1,096 (22%) women and 3,826 (78%) men; only 38% of the women were enrolled in clinical trials, whereas 46% of the men were (p < 0.0001). Within clinical trials, there were few significant eligibility differences between women and men, as the vast majority of patients met eligibility standards for entry in these trials. However, within clinical registries, the women were older (p < 0.0001) and more often had elevated blood pressure on admission (p = 0.002). Multivariate logistic regression indicated that after adjustment for significant predictors of trial inclusion, women were 25% less likely to be included in clinical trials (odds ratio = 0.76, 95% confidence interval = 0.60, 0.96). In order to counter bias introduced by the exclusion of women from clinical trials, the TPI database included patients from non-trial settings. Carefully including patients from clinical registries or non-trial settings may be an important strategy in constructing generally applicable predictive instruments.
Subject(s)
Clinical Trials as Topic/methods , Databases, Factual , Decision Support Techniques , Myocardial Infarction/drug therapy , Selection Bias , Thrombolytic Therapy , Women's Health , Aged , Female , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Patient Selection , Predictive Value of Tests , Registries , Research Design , Sex FactorsSubject(s)
Electrocardiography/methods , Body Surface Potential Mapping , Electrocardiography/instrumentation , Electrocardiography/statistics & numerical data , Humans , Medical Laboratory Science , Radiology, Interventional , Signal Processing, Computer-Assisted , Societies, Scientific/organization & administrationABSTRACT
BACKGROUND: In selecting patients with acute myocardial infarction for thrombolytic therapy, it is important to identify patients who are at high risk for intracranial hemorrhage, for whom thrombolytic therapy is ill advised. We hypothesized that presenting pulse blood pressure, representing the "hammer" effect on cerebral vessels and the effects of age on arterial compliance, might predict thrombolysis-related intracranial hemorrhage better than systolic, diastolic, or mean arterial blood pressures. METHODS AND RESULTS: Of 3483 Thrombolytic Predictive Instrument (TPI) Project subjects receiving thrombolytic therapy for acute infarction, we identified and obtained detailed clinical data on the 19 with treatment-related intracranial hemorrhages confirmed by computed tomography and on 175 matched controls. Systolic, diastolic, mean arterial, and pulse blood pressures were each significantly related to the occurrence of intracranial hemorrhage, with pulse pressure most highly related. The mean pulse pressure in patients who developed intracranial hemorrhage was 63 mm Hg, 34% higher than the 47 mm Hg mean value for those not developing hemorrhage (P = .0001). Excess pulse pressure, defined as the extent to which a patient's pulse pressure exceeded 40 mm Hg for systolic blood pressures of at least 120 mm Hg, was even more strongly related: its mean value of 23 mm Hg for patients was 130% higher than its mean value of 10 mm Hg for controls (P < .0001). With logistic regression models to estimate the relative risks (odds ratios) for intracranial hemorrhage conferred by each form of blood pressure, the relative risk for hemorrhage was greatest for excess pulse pressure: for each 10-point pulse pressure excess, the relative risk for intracranial hemorrhage was increased by 1.85 (P = .0002; 95% confidence interval [CI], 1.34 to 2.55) by itself and 1.76 (P = .001; 95% CI, 1.26 to 2.46) when adjusted for age. In this sample, excess pulse pressure by itself predicted hemorrhage as well as systolic pressure and age together. When excess pulse pressure was combined with age to make a logistic regression model predicting intracranial hemorrhage, age contributed less to the prediction than when combined with the other blood pressure forms, even though this model predicted better than any other combination of age and pressure (receiver-operating characteristic curve area, 0.82 versus 0.77 with systolic pressure and age, 0.75 with mean arterial pressure, 0.71 with diastolic pressure, and 0.81 with both systolic and diastolic pressures). CONCLUSIONS: We found that excess pulse blood pressure predicted thrombolysis-related intracranial hemorrhage better than other forms of pretreatment blood pressure, perhaps better describing the pathophysiology of intracranial hemorrhage, including the effect of age. These findings will need confirmation in larger studies with comparable clinical detail.
Subject(s)
Blood Pressure , Cerebral Hemorrhage/etiology , Models, Cardiovascular , Pulse , Thrombolytic Therapy/adverse effects , Aged , Cerebrovascular Disorders/etiology , Clinical Trials as Topic , Female , Forecasting , Humans , Male , Middle Aged , Odds Ratio , Regression AnalysisABSTRACT
Hypertrophy of noninfarcted myocardium occurs as a chronic response to myocardial infarction, but no previous study has related the changes in wall thickness to serial changes in left ventricular function. Thus the functional significance of postinfarction hypertrophy is unknown. The purpose of this study was to determine the relationship between the development of postinfarction hypertrophy and the resting left ventricular ejection fraction measured by two-dimensional echocardiography. After occlusion of the proximal left anterior descending coronary artery in 11 dogs, the ejection fraction fell acutely (0.63 +/- 0.08 to 0.33 +/- 0.10, p less than 0.001) and rose at 3.5 months to 0.62 +/- 0.12. End-diastolic thickness of the noninfarcted left ventricle increased (11 +/- 1.0 mm to 13 +/- 1.4 mm, p less than 0.01) as did left ventricular mass (101 +/- 18 gm to 134 +/- 21 gm, p less than 0.0001). Restoration of the ejection fraction toward the baseline value correlated with the increases in left ventricular mass (r = 0.79, p = 0.007) and wall thickness (r = 0.71, p = 0.025). Hypertrophy of the noninfarcted myocardium correlated with the magnitude and approximately paralleled the time course of the improvement in the ejection fraction and therefore may have had a beneficial effect on resting left ventricular function as a chronic adaptation to myocardial infarction.